Karen A. Wager
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Karen A. Wager has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Frances Wickham Lee
3 shared publicationsAndrea W White
2 shared publicationsDavid M Ward
2 shared publicationsAbby Swanson Kazley
1 shared publication- Amy Jackson
Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
1 shared publication Anne Osborne Kilpatrick
1 shared publication
Latest Publications
- Open Access
- 27 July 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (8) , 1228
Lessons Learned from the Pilot Phase of a Population-Wide Genomic Screening Program: Building the Base to Reach a Diverse Cohort of 100,000 Participants
Background and Objectives: Genomic information is increasingly relevant for disease prevention and risk management at the individual and population levels. Screening healthy adults for Tier 1 conditions of hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia using a population-based approach can help identify the 1–2% of the US population at increased risk of developing diseases associated with these conditions and tailor prevention strategies. Our objective is to report findings from an implementation science study that evaluates multi-level facilitators and barriers to implementation of the In Our DNA SC population-wide genomic screening initiative. Methods: We established an IMPACTeam (IMPlementAtion sCience for In Our DNA SC Team) to evaluate the pilot phase using principles of implementation science. We used a parallel convergent mixed methods approach to assess the Reach, Implementation, and Effectiveness outcomes from the RE-AIM implementation science framework during the pilot phase of In Our DNA SC. Quantitative assessment included the examination of frequencies and response rates across demographic categories using chi-square tests. Qualitative data were audio-recorded and transcribed, with codes developed by the study team based on the semi-structured interview guide. Results: The pilot phase (8 November 2021, to 7 March 2022) included recruitment from ten clinics throughout South Carolina. Reach indicators included enrollment rate and representativeness. A total of 23,269 potential participants were contacted via Epic’s MyChart patient portal with 1976 (8.49%) enrolled. Black individuals were the least likely to view the program invitation (28.9%) and take study-related action. As a result, there were significantly higher enrollment rates among White (10.5%) participants than Asian (8.71%) and Black (3.46%) individuals (p < 0.0001). Common concerns limiting reach and participation included privacy and security of results and the impact participation would have on health or life insurance. Facilitators included family or personal history of a Tier 1 condition, prior involvement in genetic testing, self-interest, and altruism. Assessment of implementation (i.e., adherence to protocols/fidelity to protocols) included sample collection rate (n = 1104, 55.9%) and proportion of samples needing recollection (n = 19, 1.7%). There were no significant differences in sample collection based on demographic characteristics. Implementation facilitators included efficient collection processes and enthusiastic clinical staff. Finally, we assessed the effectiveness of the program, finding low dropout rates (n = 7, 0.35%), the identification of eight individuals with Tier 1 conditions (0.72% positive), and high rates of follow-up genetic counseling (87.5% completion). Conclusion: Overall, Asian and Black individuals were less engaged, with few taking any study-related actions. Strategies to identify barriers and promoters for the engagement of diverse populations are needed to support participation. Once enrolled, individuals had high rates of completing the study and follow-up engagement with genetic counselors. Findings from the pilot phase of In Our DNA SC offer opportunities for improvement as we expand the program and can provide guidance to organizations seeking to begin efforts to integrate population-wide genomic screening.
- 27 July 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (8) , 1228
Open AccessLessons Learned from the Pilot Phase of a Population-Wide Genomic Screening Program: Building the Base to Reach a Diverse Cohort of 100,000 Participants
Background and Objectives: Genomic information is increasingly relevant for disease prevention and risk management at the individual and population levels. Screening healthy adults for Tier 1 conditions of hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia using a population-based approach can help identify the 1–2% of the US population at increased risk of developing diseases associated with these conditions and tailor prevention strategies. Our objective is to report findings from an implementation science study that evaluates multi-level facilitators and barriers to implementation of the In Our DNA SC population-wide genomic screening initiative. Methods: We established an IMPACTeam (IMPlementAtion sCience for In Our DNA SC Team) to evaluate the pilot phase using principles of implementation science. We used a parallel convergent mixed methods approach to assess the Reach, Implementation, and Effectiveness outcomes from the RE-AIM implementation science framework during the pilot phase of In Our DNA SC. Quantitative assessment included the examination of frequencies and response rates across demographic categories using chi-square tests. Qualitative data were audio-recorded and transcribed, with codes developed by the study team based on the semi-structured interview guide. Results: The pilot phase (8 November 2021, to 7 March 2022) included recruitment from ten clinics throughout South Carolina. Reach indicators included enrollment rate and representativeness. A total of 23,269 potential participants were contacted via Epic’s MyChart patient portal with 1976 (8.49%) enrolled. Black individuals were the least likely to view the program invitation (28.9%) and take study-related action. As a result, there were significantly higher enrollment rates among White (10.5%) participants than Asian (8.71%) and Black (3.46%) individuals (p < 0.0001). Common concerns limiting reach and participation included privacy and security of results and the impact participation would have on health or life insurance. Facilitators included family or personal history of a Tier 1 condition, prior involvement in genetic testing, self-interest, and altruism. Assessment of implementation (i.e., adherence to protocols/fidelity to protocols) included sample collection rate (n = 1104, 55.9%) and proportion of samples needing recollection (n = 19, 1.7%). There were no significant differences in sample collection based on demographic characteristics. Implementation facilitators included efficient collection processes and enthusiastic clinical staff. Finally, we assessed the effectiveness of the program, finding low dropout rates (n = 7, 0.35%), the identification of eight individuals with Tier 1 conditions (0.72% positive), and high rates of follow-up genetic counseling (87.5% completion). Conclusion: Overall, Asian and Black individuals were less engaged, with few taking any study-related actions. Strategies to identify barriers and promoters for the engagement of diverse populations are needed to support participation. Once enrolled, individuals had high rates of completing the study and follow-up engagement with genetic counselors. Findings from the pilot phase of In Our DNA SC offer opportunities for improvement as we expand the program and can provide guidance to organizations seeking to begin efforts to integrate population-wide genomic screening.
- 1 July 2010
- Published by Wolters Kluwer Health in CIN: Computers, Informatics, Nursing
- Vol. 28 (4) , 205-212
Comparison of the Quality and Timeliness of Vital Signs Data Using Three Different Data-Entry Devices
It is important to evaluate the impact of clinical information systems on the quality and timeliness of documentation in the patient's record to ensure the systems are improving clinical care processes and providing value to the organization. An observational study was conducted to measure the accuracy and timeliness of vital signs data during three different stages of clinical documentation system implementation at a large academic medical center: (1) a paper medical record system, (2) a clinical documentation system with "computers on wheels" workstation outside the patient's room, and (3) a clinical documentation system with a Tablet PC affixed to the vital signs monitor. Patient observations (n = 270) were completed as patient care technicians made routine vital sign rounds. Equipping patient care technicians with a Tablet PC affixed to the vital signs monitor significantly improved (P < .05) the accuracy and timeliness of vital signs. In addition, a number of unintended consequences were discovered that proved helpful to the nurse managers and nursing informatics leadership team in providing support of the new system. Findings from this study emphasize the importance of ensuring that staff has the appropriate devices needed to effectively document patient care at the bedside.
- 1 July 2010
- Published by Wolters Kluwer Health in CIN: Computers, Informatics, Nursing
- Vol. 28 (4) , 205-212
Comparison of the Quality and Timeliness of Vital Signs Data Using Three Different Data-Entry Devices
It is important to evaluate the impact of clinical information systems on the quality and timeliness of documentation in the patient's record to ensure the systems are improving clinical care processes and providing value to the organization. An observational study was conducted to measure the accuracy and timeliness of vital signs data during three different stages of clinical documentation system implementation at a large academic medical center: (1) a paper medical record system, (2) a clinical documentation system with "computers on wheels" workstation outside the patient's room, and (3) a clinical documentation system with a Tablet PC affixed to the vital signs monitor. Patient observations (n = 270) were completed as patient care technicians made routine vital sign rounds. Equipping patient care technicians with a Tablet PC affixed to the vital signs monitor significantly improved (P < .05) the accuracy and timeliness of vital signs. In addition, a number of unintended consequences were discovered that proved helpful to the nurse managers and nursing informatics leadership team in providing support of the new system. Findings from this study emphasize the importance of ensuring that staff has the appropriate devices needed to effectively document patient care at the bedside.
- 1 April 2005
- Vol. 76 (4) , 38-41
Physicians, Patients, and EHRs. When it comes to a consultation, is three a crowd?
- 1 April 2005
- Vol. 76 (4) , 38-41
Physicians, Patients, and EHRs. When it comes to a consultation, is three a crowd?
- 1 November 2004
- Published by Wiley in Public Health Nursing
- Vol. 21 (6) , 541-546
Qualitative Evaluation of South Carolina's Postpartum/Infant Home Visit Program
Many states have introduced home visitation pro- grams to improve the health of mothers and newborn infants. In South Carolina, the Postpartum/Infant Home Visit (P/IHV) program seeks to provide all Medicaid-eligible mothers and infants with at least one home visit by a nurse or other qualified health professional. In the summer 2002, the authors conducted a cost-benefit analysis of the P/IHVprogram using both qualitative and quantitative methods. This article describes the qualitative methods and findings from the larger study. Focus groups were held with nurses who provide P/IHVvisits to gain insight into the structure and functioning of the P/IHV program, to hear firsthand the nurses' experiences with the program, and to provide guidance in developing the empiric model for measuring cost-benefit. Analysis of the focus-group data suggests that what actually occurs during a home visit is fairly standardized. Nurses indicated that they were knowledge- able about community resources and services available to the families they serve. Referral processes were identified as an important factor in determining whether a mother receives a home visit. Overall, the nurses felt that the home visit program has had a positive impact on the health and well-being of the mothers and infants served.
- 1 November 2004
- Published by Wiley in Public Health Nursing
- Vol. 21 (6) , 541-546
Qualitative Evaluation of South Carolina's Postpartum/Infant Home Visit Program
Many states have introduced home visitation pro- grams to improve the health of mothers and newborn infants. In South Carolina, the Postpartum/Infant Home Visit (P/IHV) program seeks to provide all Medicaid-eligible mothers and infants with at least one home visit by a nurse or other qualified health professional. In the summer 2002, the authors conducted a cost-benefit analysis of the P/IHVprogram using both qualitative and quantitative methods. This article describes the qualitative methods and findings from the larger study. Focus groups were held with nurses who provide P/IHVvisits to gain insight into the structure and functioning of the P/IHV program, to hear firsthand the nurses' experiences with the program, and to provide guidance in developing the empiric model for measuring cost-benefit. Analysis of the focus-group data suggests that what actually occurs during a home visit is fairly standardized. Nurses indicated that they were knowledge- able about community resources and services available to the families they serve. Referral processes were identified as an important factor in determining whether a mother receives a home visit. Overall, the nurses felt that the home visit program has had a positive impact on the health and well-being of the mothers and infants served.
- 1 April 2004
- Vol. 75 (4) , 36-9; quiz 41
Research lessons. Designing a study for a clinical setting.